NICOLE COLANDREA: Open Payments
NPI 1366032484 · HOBOKEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,620 in 157 payments from 20 companies in 2025. Trend: 2023 $1,536 · 2024 $1,840 · 2025 $2,620
Food & beverage: $2,620
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $288 |
| Arcutis Biotherapeutics, Inc. | 24 | $281 |
| Galderma Laboratories, L.P. | 10 | $252 |
| PFIZER INC. | 17 | $245 |
| UCB, Inc. | 14 | $200 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $171 |
| LEO Pharma Inc. | 10 | $156 |
| Journey Medical Corporation | 7 | $139 |
| Regeneron Healthcare Solutions, Inc. | 7 | $129 |
| Incyte Corporation | 6 | $105 |
Products named: Zoryve, Bimzelx, DUPIXENT, CIBINQO, NEMLUVIO, SKYRIZI, ADBRY, Winlevi.
Industry payments across NJ — which companies pay providers there.
